anti-her2 therapy for breast cancer ana lilia castruita-avila, m.d.
Published 5 years ago • 443 plays • Length 12:40Download video MP4
Download video MP3
Similar videos
-
1:03
is there any alternative treatment for breast cancer? - dr. nanda rajaneesh
-
0:45
dr. hamilton on using pcr to classify risk in her2 breast cancer
-
1:37
dr. traina on conversations on extended adjuvant therapy with neratinib in her2 breast cancer
-
3:12
combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression
-
2:33
challenges with neoadjuvant endocrine therapy in breast cancer
-
2:25
reducing risk in residual breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
4:01
duration of endocrine therapy in breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:27
treating er breast cancer patients with endocrine therapy resistance
-
5:01
neoadjuvant lapatinib in her2 early breast cancer
-
4:56
neoadjuvant talazoparib active in brca-mutated early breast cancer | jennifer litton
-
2:33
who should receive combination therapy for er positive breast cancer?
-
7:37
dr. tolaney highlights new breast cancer combination therapies
-
1:47
evaluating the role of neoadjuvant endocrine therapy in breast cancer
-
15:51
considerations for pre-operative therapy to optimize care of women with her2 breast cancer
-
2:55
e2112: endocrine therapy plus entinostat in hr advanced breast cancer
-
8:30
hr breast cancer: endocrine therapy, surgery and radiotherapy
-
24:33
20221005 talk with a doc - breast cancer